Skip to Main Navigation

Essential Public Health Functions Programs II Project

Abstract*

The objectives of the Second Essential Public Health Functions and programs Project are to: (i) improve the stewardship role of the federal public health system, through the strengthening of the essential public health functions, and (ii) increase the coverage and clinical governance of priority public health programs in Argentina. The Project has three components. Component one comprises of the strengthening of the National Ministry of Health (MSN)...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The PDOs are to: (i) improve the stewardship role of the federal public health system, through the strengthening of Essential Public Health Functions; and (ii) increase the coverage and clinical governance of Priority Public Health Programs

Key Details

Project Details

  • P110599

  • Closed

  • Luis Perez

  • Argentine Republic

  • Argentina

  • July 20, 2010

  • (as of board presentation)

    December 20, 2010

  • August 3, 2011

  • US$ 461.00 million

  • Ministerio de Salud de la Nacion

  • Latin America and Caribbean

  • 2011

  • US$ 461.00 million

  • B

  • Not Applicable

  • April 30, 2018

  • BANK APPROVED

  • April 25, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
International Bank for Reconstruction and Development 461.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 461.00
IDA Commitment N/A
IBRD + IDA Commitment 461.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 461.00

Summary Status of World Bank Financing (US$ Millions) as of July 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of July 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Sep 15, 2015 IBRD-79930 Int Charges 837.70
Sep 15, 2015 IBRD-79930 Int Charges 1,816,008.80
Dec 14, 2015 IBRD-79930 Loan Disb 2,184,976.80
Sep 15, 2022 IBRD-79930 Int Charges 3,219,437.00
Sep 15, 2022 IBRD-79930 Loan Repay 8,191,383.50
Sep 15, 2022 IBRD-79930 Loan Repay 3,219,437.00
Mar 15, 2023 IBRD-79930 Int Charges 770,318.20
Mar 15, 2023 IBRD-79930 Loan Repay 210,666.08
Mar 15, 2023 IBRD-79930 Loan Repay 868,637.60
Mar 15, 2023 IBRD-79930 Int Charges 7,082,225.00
Mar 15, 2023 IBRD-79930 Loan Repay 6,570,162.50
Mar 15, 2023 IBRD-79930 Loan Repay 84,583.53
Sep 15, 2023 IBRD-79930 Int Charges 1,814,495.80
Sep 15, 2023 IBRD-79930 Loan Repay 11,410,820.00
Sep 15, 2023 IBRD-79930 Int Charges 126,660.80
Sep 15, 2023 IBRD-79930 Int Charges 7,531,384.00
Mar 15, 2024 IBRD-79930 Int Charges 10,008,813.00
Mar 15, 2024 IBRD-79930 Int Charges 164,294.90
Mar 15, 2024 IBRD-79930 Loan Repay 11,410,820.00
Dec 20, 2010 IBRD-79930 Loan Commitment 461,000,000.00
Sep 15, 2017 IBRD-79930 Int Charges 4,517,864.00
Oct 18, 2017 IBRD-79930 Loan Disb 9,523,793.00
Dec 26, 2017 IBRD-79930 Loan Disb 5,204,826.50
Mar 15, 2018 IBRD-79930 Int Charges 4,689,603.00
Mar 15, 2018 IBRD-79930 Loan Repay 6,746,576.50
Mar 15, 2018 IBRD-79930 Loan Repay 4,689,603.00
Sep 15, 2018 IBRD-79930 Loan Repay 11,436,179.00
Sep 15, 2018 IBRD-79930 Int Charges 6,585,447.50
Nov 20, 2018 IBRD-79930 Loan Disb -939,864.00
Nov 20, 2018 IBRD-79930 Loan Cancel 15,214,107.00
Mar 15, 2019 IBRD-79930 Loan Repay 6,916,124.50
Mar 15, 2019 IBRD-79930 Int Charges 6,916,124.50
Mar 15, 2019 IBRD-79930 Loan Repay 4,494,696.00
Sep 15, 2019 IBRD-79930 Loan Repay 2,063,335.10
Sep 15, 2019 IBRD-79930 Loan Repay 2,820,000.00
Sep 15, 2019 IBRD-79930 Loan Repay 997,337.06
Sep 15, 2019 IBRD-79930 Loan Repay 2,789,867.50
Sep 15, 2019 IBRD-79930 Loan Repay 194,372.78
Sep 15, 2019 IBRD-79930 Loan Repay 637,508.50
Sep 15, 2019 IBRD-79930 Int Charges 652,143.30
Sep 15, 2019 IBRD-79930 Int Charges 167,272.17
Mar 15, 2016 IBRD-79930 Int Charges 7,153.75
Mar 15, 2016 IBRD-79930 Int Charges 2,221,281.20
Sep 15, 2016 IBRD-79930 Int Charges 3,057,368.20
Sep 7, 2016 IBRD-79930 Loan Disb 8,095,281.00
Nov 23, 2016 IBRD-79930 Loan Disb 7,539,041.00
Mar 15, 2017 IBRD-79930 Int Charges 2,662.45
Mar 15, 2017 IBRD-79930 Int Charges 3,899,051.20
Mar 16, 2017 IBRD-79930 Loan Disb 1,298,201.60
Jun 7, 2017 IBRD-79930 Loan Disb 10,888,441.00
Oct 2, 2014 IBRD-79930 Loan Disb 3,271,736.50
Nov 20, 2014 IBRD-79930 Loan Disb 29,400,006.00
Dec 3, 2014 IBRD-79930 Loan Disb 8,467,158.00
Sep 10, 2013 IBRD-79930 Loan Disb 1,418,041.90
Nov 26, 2013 IBRD-79930 Loan Disb 927,395.50
Dec 9, 2013 IBRD-79930 Loan Disb 26,105,622.00
Aug 6, 2013 IBRD-79930 Loan Disb 12,968,295.00
Sep 15, 2013 IBRD-79930 Int Charges 992,544.50
Dec 27, 2013 IBRD-79930 Loan Disb 7,488,174.50
Dec 27, 2013 IBRD-79930 Loan Disb 47,111,824.00
Mar 15, 2014 IBRD-79930 Int Charges 13,145.56
Mar 15, 2014 IBRD-79930 Int Charges 1,220,053.00
Sep 15, 2014 IBRD-79930 Int Charges 0.01
Sep 15, 2014 IBRD-79930 Int Charges 1,345,998.60
Mar 10, 2015 IBRD-79930 Loan Disb 7,266,892.00
Jun 16, 2015 IBRD-79930 Loan Disb 9,016,568.00
Mar 15, 2015 IBRD-79930 Int Charges 1,483,938.50
Sep 15, 2021 IBRD-79930 Loan Repay 1,701,652.90
Sep 15, 2021 IBRD-79930 Int Charges 1,701,652.90
Sep 15, 2021 IBRD-79930 Loan Repay 9,709,168.00
Mar 15, 2022 IBRD-79930 Int Charges 1,568,238.10
Mar 15, 2022 IBRD-79930 Loan Repay 11,410,820.00
Mar 15, 2023 IBRD-79930 Int Charges 123,990.60
Mar 15, 2023 IBRD-79930 Loan Repay 1,480,378.80
Mar 15, 2023 IBRD-79930 Int Charges 296,787.34
Mar 15, 2023 IBRD-79930 Int Charges 94,480.18
Mar 15, 2023 IBRD-79930 Int Charges 10,916.49
Mar 15, 2023 IBRD-79930 Int Charges 379,453.72
Mar 15, 2023 IBRD-79930 Loan Repay 2,196,392.00
Sep 15, 2019 IBRD-79930 Loan Repay 683,186.75
Sep 15, 2019 IBRD-79930 Int Charges 1,882,078.90
Sep 15, 2019 IBRD-79930 Loan Repay 1,225,212.90
Sep 15, 2019 IBRD-79930 Int Charges 4,087,495.50
Sep 15, 2019 IBRD-79930 Int Charges 319,948.03
Mar 15, 2020 IBRD-79930 Int Charges 5,542,162.00
Mar 15, 2020 IBRD-79930 Loan Repay 5,868,658.50
Mar 15, 2020 IBRD-79930 Loan Repay 5,542,162.00
Sep 15, 2020 IBRD-79930 Loan Repay 11,410,820.00
Sep 15, 2020 IBRD-79930 Int Charges 2,820,960.80
Mar 15, 2021 IBRD-79930 Loan Repay 9,551,926.00
Mar 15, 2021 IBRD-79930 Loan Repay 1,858,894.40
Mar 15, 2021 IBRD-79930 Int Charges 1,858,894.40
Aug 28, 2015 IBRD-79930 Loan Disb 15,384,393.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Project Management Satisfactory 2018-04-30
Monitoring and Evaluation Satisfactory 2018-04-30
Overall Implementation Progress (IP) Moderately Satisfactory 2018-04-30
Procurement Moderately Unsatisfactory 2018-04-30
Progress towards achievement of PDO Moderately Satisfactory 2018-04-30
Financial Management Moderately Satisfactory 2018-04-30

COMPLETION RATINGS

INDICATORIMPLEMENTATION COMPLETION & RESULTS REPORT: 12-13-2018
OutcomesSubstantial
Risk to Development Outcome
Bank PerformanceSubstantial
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

INDICATORICR REVIEW: 05-30-2019PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome RatingModerately Satisfactory N/a
Risk To Development OutcomeN/a
Bank PerformanceModerately SatisfactoryN/a
Borrower PerformanceN/a
Government PerformanceNot RatedN/a
Implementing AgencyN/a
Icr QualitySubstantialN/a
M&e QualitySubstantialN/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Increased percentage of children under one year of age vaccinated with pentavalent vaccine.Value93.6095.0088.00
    DateDecember 20, 2010April 30, 2018April 30, 2018
    Comment
  • Increased percentage of certified departments or local territories with satisfactory or highly satisfactory epidemiological surveillance nodes (C2).Value0.0080.0075.00
    DateDecember 20, 2010April 30, 2018March 30, 2018
    Comment
  • Increased kilograms of blood-plasma produced by MSN and provincial labsValue33000.0040000.0043557.00
    DateDecember 20, 2010April 30, 2018March 30, 2018
    Comment
  • Reduction of the tobacco consumption prevalence in adults 18-64Value30.0027.0025.10
    DateDecember 20, 2010April 30, 2018March 30, 2018
    Comment
  • At least 200 out of the 700 participating municipalities certified as Health Responsible MunicipalitiesValue0.00200.00200.00
    DateDecember 20, 2010April 30, 2018March 30, 2018
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of intensive health care units evaluated and properly registered in the system.Value0.00400.00633.00
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Increased number of PROFE population from Tucuman and Misiones enrolled in a clinical governance program for kidney disease prevention and control.Value0.004000.002562.00
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Health facilities constructed, renovated, and/or equipped (number)Value0.0012.001.00
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Number of technical audits on clinical effectiveness of the diseases of low incidence and higher cost, renal disease and haemophilia.Value0.002.003.00
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Number of tobacco free municipalities.Value0.00140.00142.00
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Number of PROFE women with more than 7 children having signed their letter of rights.Value0.0040000.008477.00
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Percentage of PROFE renal chronic dialysis patients evaluated and included in SINTRA.Value0.0080.0095.10
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Percentage of PROFE newly diagnosed patients with renal chronic dialysis evaluated within six months of beginning dialysis.Value0.0080.00100.00
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Percentage of PROFE beneficiaries with low incidence high cost diseases included in the PROFE health care chain.Value0.0050.0083.30
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Percentage of operational HIV/AIDS Counseling and Testing Centers.Value0.0070.0070.60
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Increased participation of provinces in training of health personnel in public healthValue0.0024.0024.00
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Number of pilot studies with nutritional sprinkles component (to reduce iron deficiency anemia)Value0.002.000.00
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Health personnel receiving training (number)Value0.00800.001665.00
    DateMarch 31, 2011April 30, 2018October 31, 2017
    Comment
  • Percentage of women between 40 and 70 years old in the province of Tucuman benefiting from at least one mammography provided by thehealth system.Value10.0060.0090.80
    DateDecember 20, 2010April 30, 2018October 31, 2017
    Comment
  • Blood donations per 1000 inhabitants over 18 years oldValue25.6030.6030.90
    DateDecember 20, 2010April 30, 2018December 29, 2017
    Comment
  • Percentage of women between 35 and 64 in Tucuman benefiting from at least one PHV and/or citology test provided by the health systemValue10.0060.0076.60
    DateNovember 1, 2010April 30, 2018December 29, 2017
    Comment
  • Percentage of women between 35 and 64 in Misiones benefiting from at least one PHV and/or citology test provided by the health systemValue10.0060.0076.60
    DateNovember 1, 2010April 30, 2018October 31, 2017
    Comment
  • Percentage of women between 50 and 69 years old in the province of Misiones benefiting from at least one mammography provided by the health system.Value10.0060.0090.80
    DateNovember 1, 2010April 30, 2018December 29, 2017
    Comment